Ronald A. Paulus, MD
Ronald A. Paulus, MD, is President and CEO of RAPMD Strategic Advisors, providing advisory services to health system Boards, CEOs, technology companies and others. He also serves as an Executive in Residence with General Catalyst. He has served on numerous diverse Boards, including a public company, private equity backed enterprises, health systems and academic institutions.
Dr. Paulus also is the immediate past President and CEO of Mission Health, a $2 billion integrated health system serving all of western North Carolina. Before joining Mission Health, Dr. Paulus was Chief Administrative and Chief Innovation Officer for Geisinger Health System. Prior to joining Geisinger, Dr. Paulus was co-founder, President and later CEO of CareScience, Inc. (a NASDAQ company), later acquired by Premier, Inc. (NASDAQ: PINC;) providing an analytics platform to support health systems’ quality and efficiency improvement work used today by nearly 1,000 hospitals nationwide.
Dr. Paulus received his MD degree from The School of Medicine, University of Pennsylvania, and his MBA, concentration in healthcare management, and BS in Economics from The Wharton School, University of Pennsylvania. He has published peer-reviewed book chapter and journal articles (including in the Annals of Internal Medicine, New England Journal of Medicine and Health Affairs), and speaks regularly on the topics of health care quality and efficiency, innovation, physician and health system leadership and new models of care. Dr. Paulus has testified before both the US House (on the 340b Drug Program) and the US Senate (the Stark and anti-kickback laws) and he has been named one of Modern Healthcare’s Top 50 Most Influential Physician Executives and Leaders several times, and was recently among the Top 15 on that list.